Lung cancer differential diagnosis: Difference between revisions
Ahmed Younes (talk | contribs) No edit summary |
Farima Kahe (talk | contribs) |
||
(One intermediate revision by one other user not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Lung cancer must be differentiated from other | Lung cancer must be differentiated from other conditions that cause [[hemoptysis]], [[cough]], [[dyspnea]], [[wheeze|wheezing]], [[chest pain]], [[dysphonia]], [[dysphagia]], unexplained [[weight loss]], unexplained [[loss of appetite]], and [[fatigue]]. These conditions include [[pneumonia]], [[bronchitis]], [[metastatic cancer]] from a non-[[Chest|thoracic]] primary site, [[infectious]] [[granuloma]], [[Tuberculosis|pulmonary tuberculosis]], [[Trachea|tracheal]] [[Tumor|tumors]], and a [[thyroid]] mass. | ||
==Differentiating Lung Cancer from Other Diseases== | ==Differentiating Lung Cancer from Other Diseases== | ||
==='''The following table summarizes the differentiation of various lung tumors based on histological and topographical features:'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref>=== | |||
=== '''The following table summarizes the differentiation of various lung tumors based on histological and topographical features:'''<ref name="pmid10682770">{{cite journal |vauthors=Erasmus JJ, Connolly JE, McAdams HP, Roggli VL |title=Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions |journal=Radiographics |volume=20 |issue=1 |pages=43–58 |date=2000 |pmid=10682770 |doi=10.1148/radiographics.20.1.g00ja0343 |url=}}</ref> === | |||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="11" |Abrevations: | ! colspan="11" |Abrevations: | ||
Line 159: | Line 31: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Squamous cell papilloma]]''' | ||
| | | | ||
* [[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]] | *[[Human papillomavirus|HPV 6]] and [[Human papillomavirus|11]] | ||
* Men | * Men | ||
* Median age of diagnosis is 54 years | * Median age of diagnosis is 54 years | ||
| | | | ||
* [[Epithelial cells]] | *[[Epithelial cells]] | ||
| | | | ||
* Endobronchial | * Endobronchial | ||
Line 174: | Line 46: | ||
* Acanthosis | * Acanthosis | ||
* Binucleate forms and perinuclear halos | * Binucleate forms and perinuclear halos | ||
* [[Koilocytosis]] | *[[Koilocytosis]] | ||
| | | | ||
* N/A | * N/A | ||
Line 190: | Line 62: | ||
* Mean age of diagnosis is 68 years | * Mean age of diagnosis is 68 years | ||
| | | | ||
* [[Goblet cells]] of [[respiratory epithelium]] | *[[Goblet cells]] of [[respiratory epithelium]] | ||
| | | | ||
* Endobronchial | * Endobronchial | ||
Line 220: | Line 92: | ||
* All lung lobes | * All lung lobes | ||
* Lower lobes | * Lower lobes | ||
* Hilar | * Hilar | ||
| | | | ||
* 0.7-6.0 cm | * 0.7-6.0 cm | ||
* Well demarcated smooth | * Well demarcated smooth | ||
* Lobulated, multicystic | * Lobulated, multicystic | ||
Line 228: | Line 100: | ||
* Pale yellow to tan cut surfaces | * Pale yellow to tan cut surfaces | ||
| | | | ||
* Non-encapsulated | * Non-encapsulated | ||
* Multicystic masses | * Multicystic masses | ||
* [[Cuboidal cells|Cuboidal cell]] linning | *[[Cuboidal cells|Cuboidal cell]] linning | ||
* Squamous metaplasia | * Squamous metaplasia | ||
* Myxoid and [[Collagen|collagenous]] interstitium | * Myxoid and [[Collagen|collagenous]] interstitium | ||
| | | | ||
* [[Keratin]] | *[[Keratin]] | ||
* [[CEA]] | *[[CEA]] | ||
* Surfactant protein | * Surfactant protein | ||
* [[TTF-1]] | *[[TTF-1]] | ||
* [[Actin]] | *[[Actin]] | ||
| | | | ||
* Well circumscribed | * Well circumscribed | ||
Line 259: | Line 131: | ||
* Well defined | * Well defined | ||
* Encapsulated | * Encapsulated | ||
* Soft, spongy to firm mass | * Soft, spongy to firm mass | ||
* Granular gray white/ brown | * Granular gray white/ brown | ||
* 1.0- 4.0 cm | * 1.0- 4.0 cm | ||
| | | | ||
* [[Infiltration (medical)|Infiltration]] | *[[Infiltration (medical)|Infiltration]] | ||
* [[Papillary]] growth pattern | *[[Papillary]] growth pattern | ||
* Fibrovascular cores | * Fibrovascular cores | ||
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning | *[[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning | ||
* Cilitated and oxyphilic cells | * Cilitated and oxyphilic cells | ||
* Occasional [[eosinophilic]] intranuclear inclusions | * Occasional [[eosinophilic]] intranuclear inclusions | ||
| | | | ||
* [[Cytokeratin]] | *[[Cytokeratin]] | ||
* [[Clara cell secretory protein|Clara cell protein]] | *[[Clara cell secretory protein|Clara cell protein]] | ||
* [[TTF-1]] | *[[TTF-1]] | ||
* Surfactant apoprotein | * Surfactant apoprotein | ||
* [[CEA]] | *[[CEA]] | ||
| | | | ||
* Incidental finding | * Incidental finding | ||
Line 282: | Line 154: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenoma''' | ||
| | | | ||
* No sex predilection | * No sex predilection | ||
* Mean age of diagnosis is 52 years | * Mean age of diagnosis is 52 years | ||
| | | | ||
Line 289: | Line 161: | ||
* Central | * Central | ||
| | | | ||
* White-pink to tan | * White-pink to tan | ||
* Smooth and shiny tumors | * Smooth and shiny tumors | ||
* Gelatinous mucoid solid core | * Gelatinous mucoid solid core | ||
* 0.7-7.5 cm | * 0.7-7.5 cm | ||
| | | | ||
* Numerous [[mucin]]-filled cystic spaces | * Numerous [[mucin]]-filled cystic spaces | ||
* Non-dilated microacini, glands, tubules and papillae | * Non-dilated microacini, glands, tubules and papillae | ||
| | | | ||
* EMA | * EMA | ||
* [[Cytokeratin|Cytokeratins]] | *[[Cytokeratin|Cytokeratins]] | ||
* [[CEA]] | *[[CEA]] | ||
| | | | ||
* Coin lesion | * Coin lesion | ||
* Air-meniscus sign | * Air-meniscus sign | ||
| | | | ||
Line 321: | Line 193: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary''' | ||
| rowspan="3" | | | rowspan="3" | | ||
* Cigarette smokers | * Cigarette smokers | ||
* [[Arsenic]] | *[[Arsenic]] | ||
| rowspan="3" | | | rowspan="3" | | ||
* Epithelial cells | * Epithelial cells | ||
Line 329: | Line 201: | ||
| rowspan="3" | | | rowspan="3" | | ||
* White or grey lesions | * White or grey lesions | ||
* Focal carbon pigment deposits | * Focal carbon pigment deposits | ||
* [[Cavitation|Cavitations]] | *[[Cavitation|Cavitations]] | ||
* Intraluminal polypoid masses | * Intraluminal polypoid masses | ||
* [[Infiltration (medical)|Infiltration]] | *[[Infiltration (medical)|Infiltration]] | ||
| | | | ||
* Exophytic | * Exophytic | ||
* Intra-epithelial | * Intra-epithelial | ||
* Without invasion | * Without invasion | ||
| rowspan="3" | | | rowspan="3" | | ||
* [[Keratin]] | *[[Keratin]] | ||
* [[Cytokeratin|Cytokeratins]] | *[[Cytokeratin|Cytokeratins]] | ||
* [[CEA]] | *[[CEA]] | ||
* [[Thyroid transcription factor-1]] ([[TTF-1]]) | *[[Thyroid transcription factor-1]] ([[TTF-1]]) | ||
| rowspan="3" | | | rowspan="3" | | ||
* Lobar or entire lung collapse | * Lobar or entire lung collapse | ||
* Shift of the [[mediastinum]] to the ipsilateral side | * Shift of the [[mediastinum]] to the ipsilateral side | ||
* Hilar, perihilar or [[Mediastinal mass|mediastinal masses]] | * Hilar, perihilar or [[Mediastinal mass|mediastinal masses]] | ||
| rowspan="3" | | | rowspan="3" | | ||
* [[Liver]] | *[[Liver]] | ||
* [[Breast]] | *[[Breast]] | ||
* [[Bone]] | *[[Bone]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell''' | ||
Line 362: | Line 234: | ||
| colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref> | | colspan="3" style="background:#DCDCDC;" align="center" + |'''[[Small cell carcinoma]]'''<ref name="pmid16226617">{{cite journal |vauthors=Jackman DM, Johnson BE |title=Small-cell lung cancer |journal=Lancet |volume=366 |issue=9494 |pages=1385–96 |date=2005 |pmid=16226617 |doi=10.1016/S0140-6736(05)67569-1 |url=}}</ref> | ||
| | | | ||
* [[Smoking]] | *[[Smoking]] | ||
* [[Radon]] exposure | *[[Radon]] exposure | ||
| | | | ||
* Bronchial precursor cell | * Bronchial precursor cell | ||
| | | | ||
* Peripheral | * Peripheral | ||
| | | | ||
* White-tan, soft, friable perihilar masses | * White-tan, soft, friable perihilar masses | ||
* Extensive necrosis | * Extensive necrosis | ||
* 5% peripheral coin lesions | * 5% peripheral coin lesions | ||
| | | | ||
* Sheet-like growth | * Sheet-like growth | ||
* Nesting | * Nesting | ||
* Trabeculae | * Trabeculae | ||
* Peripheral palisading | * Peripheral palisading | ||
* Rosette formation | * Rosette formation | ||
* High mitotic rate | * High mitotic rate | ||
| | | | ||
* [[CD56]] | *[[CD56]] | ||
* [[Chromogranin]] | *[[Chromogranin]] | ||
* [[Synaptophysin]] | *[[Synaptophysin]] | ||
* [[TTF-1]] | *[[TTF-1]] | ||
| | | | ||
* Hilar or perihilar masses | * Hilar or perihilar masses | ||
* [[Mediastinal lymphadenopathy]] | *[[Mediastinal lymphadenopathy]] | ||
* Lobar collapse | * Lobar collapse | ||
| | | | ||
* Bone marrow | * Bone marrow | ||
* Liver | * Liver | ||
|- | |- | ||
Line 395: | Line 267: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Acinar adenocarcinoma''' | ||
| rowspan="10" | | | rowspan="10" | | ||
* [[Smoking]] | *[[Smoking]] | ||
| rowspan="10" | | | rowspan="10" | | ||
* Columnar cells of bronchioles | * Columnar cells of bronchioles | ||
Line 405: | Line 277: | ||
* Peripheral distribution | * Peripheral distribution | ||
* Gray-white central fibrosis | * Gray-white central fibrosis | ||
* [[Pleural]] puckering | *[[Pleural]] puckering | ||
* Anthracotic pigmentation | * Anthracotic pigmentation | ||
** [[Necrosis]] | **[[Necrosis]] | ||
** [[Cavitation]] | **[[Cavitation]] | ||
** [[Hemorrhage]] | **[[Hemorrhage]] | ||
* Lobulated or ill defined edges | * Lobulated or ill defined edges | ||
| | | | ||
* Irregular-shaped glands | * Irregular-shaped glands | ||
* [[Malignant]] cells: | *[[Malignant]] cells: | ||
** Hyperchromatic nuclei | ** Hyperchromatic nuclei | ||
** Fibroblastic stroma | ** Fibroblastic stroma | ||
| rowspan="10" | | | rowspan="10" | | ||
* Epithelial markers | * Epithelial markers | ||
* [[CEA]] | *[[CEA]] | ||
* [[Cytokeratin|CK7]] | *[[Cytokeratin|CK7]] | ||
* [[TTF-1]] | *[[TTF-1]] | ||
| rowspan="10" | | | rowspan="10" | | ||
* Peripheral nodules under 4.0 cm in size | * Peripheral nodules under 4.0 cm in size | ||
* Central location as a hilar or perihilar mass | * Central location as a hilar or perihilar mass | ||
* Rarely show cavitations. | * Rarely show cavitations. | ||
* Hilar adenopathy | * Hilar adenopathy | ||
* Adenocarcinomas account for the majority of small peripheral cancers identified radiologically. | * Adenocarcinomas account for the majority of small peripheral cancers identified radiologically. | ||
| rowspan="10" |Aerogenous spread is characteristic | | rowspan="10" |Aerogenous spread is characteristic | ||
* Brain | * Brain | ||
* Bone | * Bone | ||
Line 437: | Line 310: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Papillary adenocarcinoma''' | ||
| | | | ||
* [[Papillae]] | *[[Papillae]] | ||
* [[Necrosis]] | *[[Necrosis]] | ||
* Surrounding invasion | * Surrounding invasion | ||
* [[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning | *[[Cuboidal epithelia|Cuboidal]] to [[Columnar epithelia|columnar epithelial]] linning | ||
* [[Mucinous]] or non-mucinous | *[[Mucinous]] or non-mucinous | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma''' | | rowspan="3" style="background:#DCDCDC;" align="center" + |'''Bronchio-alveolar carcinoma''' | ||
| style="background:#DCDCDC;" align="center" + |'''Non-mucinous''' | | style="background:#DCDCDC;" align="center" + |'''Non-mucinous''' | ||
| | | | ||
* [[Clara cell|Clara cells]] | *[[Clara cell|Clara cells]] | ||
* [[Pneumocytes|Type II cells]] | *[[Pneumocytes|Type II cells]] | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |'''Mucinous''' | | style="background:#DCDCDC;" align="center" + |'''Mucinous''' | ||
Line 453: | Line 326: | ||
* Low grade differentiation | * Low grade differentiation | ||
* Composed of: | * Composed of: | ||
** Tall [[Columnar epithelia|columnar cells]] | ** Tall [[Columnar epithelia|columnar cells]] | ||
** Basal nuclei | ** Basal nuclei | ||
** Pale cytoplasm resembling goblet cells | ** Pale cytoplasm resembling goblet cells | ||
** Varying amounts of cytoplasmic mucin | ** Varying amounts of cytoplasmic mucin | ||
* Cytologic atypia | * Cytologic atypia | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate''' | | style="background:#DCDCDC;" align="center" + |'''Mixed non-mucinous and mucinous or indeterminate''' | ||
Line 479: | Line 352: | ||
| style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma''' | | style="background:#DCDCDC;" align="center" + |'''Mucinous cystadenocarcinoma''' | ||
| | | | ||
* Partial [[fibrous tissue]] capsule | * Partial [[fibrous tissue]] capsule | ||
* Central [[cystic]] change with [[mucin]] pooling | * Central [[cystic]] change with [[mucin]] pooling | ||
* [[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls | *[[Neoplastic]] [[mucinous]] [[epithelium]] grows along alveolar walls | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma''' | | style="background:#DCDCDC;" align="center" + |'''Signet ring adenocarcinoma''' | ||
| | | | ||
* Focal | * Focal | ||
* Cells with nuclei displaced to sides | * Cells with nuclei displaced to sides | ||
* Components of other cells are present. | * Components of other cells are present. | ||
Line 507: | Line 380: | ||
| rowspan="5" | | | rowspan="5" | | ||
* Approximately 10% of lung cancers | * Approximately 10% of lung cancers | ||
* [[Smoking]] | *[[Smoking]] | ||
| rowspan="5" | | | rowspan="5" | | ||
* [[Neuroendocrine cells|Neuro endocrine cells]] | *[[Neuroendocrine cells|Neuro endocrine cells]] | ||
* Suprabasal bronchial cells | * Suprabasal bronchial cells | ||
| rowspan="5" | | | rowspan="5" | | ||
* Peripheral masses | * Peripheral masses | ||
* [[Bronchi]] | *[[Bronchi]] | ||
| rowspan="5" | | | rowspan="5" | | ||
* Soft, pink-tan tumor | * Soft, pink-tan tumor | ||
* [[Necrosis]] and occasional [[hemorrhage]] | *[[Necrosis]] and occasional [[hemorrhage]] | ||
* [[Cavitation|Cavitations]] | *[[Cavitation|Cavitations]] | ||
* Exophytic bronchial growth | * Exophytic bronchial growth | ||
| | | | ||
*Invasive growth pattern | *Invasive growth pattern | ||
Line 532: | Line 405: | ||
* Large, peripheral masses | * Large, peripheral masses | ||
| rowspan="5" | | | rowspan="5" | | ||
* [[Pleura]] | *[[Pleura]] | ||
* [[Liver]] | *[[Liver]] | ||
* [[Bone]] | *[[Bone]] | ||
* [[Brain]] | *[[Brain]] | ||
* Abdominal [[Lymph node|lymph nodes]] | * Abdominal [[Lymph node|lymph nodes]] | ||
* [[Pericardium]] | *[[Pericardium]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Clear cell carcinoma of the lung''' | ||
| | | | ||
* [[Clear cell|Clear cells]] | *[[Clear cell|Clear cells]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Lymphoepithelioma-like carcinoma of the lung''' | ||
| | | | ||
* Syncytial growth pattern | * Syncytial growth pattern | ||
* [[Eosinophilic]] nucleoli | *[[Eosinophilic]] nucleoli | ||
* [[Lymphocyte|Lymphocytic]] infiltration | *[[Lymphocyte|Lymphocytic]] infiltration | ||
* Invasive | * Invasive | ||
* [[Amyloid]] deposition | *[[Amyloid]] deposition | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Large-cell lung carcinoma with rhabdoid phenotype''' | ||
| | | | ||
* [[Eosinophilic]] [[cytoplasmic]] globules | *[[Eosinophilic]] [[cytoplasmic]] globules | ||
* Small foci of [[adenocarcinoma]] | * Small foci of [[adenocarcinoma]] | ||
* [[Eosinophilic]] inclusions | *[[Eosinophilic]] inclusions | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Mixed type''' | ||
| | | | ||
* Mixture of: | * Mixture of: | ||
** [[Adenocarcinoma]] | **[[Adenocarcinoma]] | ||
** [[Squamous cell carcinoma]] | **[[Squamous cell carcinoma]] | ||
** Giant cell carcinoma | ** Giant cell carcinoma | ||
** Spindle cell carcinoma | ** Spindle cell carcinoma | ||
Line 581: | Line 454: | ||
* Mean age at diagnosis is 60 years | * Mean age at diagnosis is 60 years | ||
* Tobacco [[smoking]] | * Tobacco [[smoking]] | ||
* [[Asbestos|Asbestos exposure]] | *[[Asbestos|Asbestos exposure]] | ||
| rowspan="5" | | | rowspan="5" | | ||
* Undifferentiated [[epithelial cells]] | * Undifferentiated [[epithelial cells]] | ||
| rowspan="5" | | | rowspan="5" | | ||
* Central or peripheral | * Central or peripheral | ||
Line 589: | Line 462: | ||
| rowspan="5" | | | rowspan="5" | | ||
* > 5 cm | * > 5 cm | ||
* Well circumscribed | * Well circumscribed | ||
* Grey, yellow or tan creamy, gritty, | * Grey, yellow or tan creamy, gritty, | ||
* Mucoid and/or [[hemorrhagic]] with significant [[necrosis]] | * Mucoid and/or [[hemorrhagic]] with significant [[necrosis]] | ||
* [[Sessile]] or [[pedunculated]] | *[[Sessile]] or [[pedunculated]] | ||
* Infiltrative | * Infiltrative | ||
| | | | ||
Line 598: | Line 471: | ||
* Mixture of [[carcinomatous]] and sarcomatous cells | * Mixture of [[carcinomatous]] and sarcomatous cells | ||
| | | | ||
* [[Keratin]] | *[[Keratin]] | ||
* [[S-100]] | *[[S-100]] | ||
| rowspan="5" | | | rowspan="5" | | ||
* No specific imaging features | * No specific imaging features | ||
| rowspan="5" | | | rowspan="5" | | ||
* Aggressive tumor | * Aggressive tumor | ||
* [[Esophagus]], [[jejunum]], and [[rectum]] | *[[Esophagus]], [[jejunum]], and [[rectum]] | ||
* [[Kidney]] | *[[Kidney]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Spindle cell carcinoma''' | ||
Line 612: | Line 485: | ||
* Lymphoplasmacytic infiltrates | * Lymphoplasmacytic infiltrates | ||
| rowspan="3" | | | rowspan="3" | | ||
* [[Keratin]] | *[[Keratin]] | ||
* EMA | * EMA | ||
* [[Cytokeratin]] | *[[Cytokeratin]] | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[CEA]] | *[[CEA]] | ||
* [[TTF-1]] | *[[TTF-1]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Giant cell carcinoma''' | ||
Line 631: | Line 504: | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary blastoma''' | ||
| | | | ||
* Biphasic | * Biphasic | ||
* Mixture of [[Epithelium|epithelial]] and mesenchymal [[Stromal cell|stroma]] | * Mixture of [[Epithelium|epithelial]] and mesenchymal [[Stromal cell|stroma]] | ||
| | | | ||
* [[Keratin]] | *[[Keratin]] | ||
* EMA | * EMA | ||
* [[CEA]] | *[[CEA]] | ||
* [[Chromogranin A]] | *[[Chromogranin A]] | ||
|- | |- | ||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma | ||
Line 651: | Line 524: | ||
| style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref> | | style="background:#DCDCDC;" align="center" + |'''[[Carcinoid tumor]]'''<ref name="pmid19212636">{{cite journal |vauthors=Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S |title=Lung carcinoid tumor biology: treatment and survival |journal=Oncol. Rep. |volume=21 |issue=3 |pages=757–60 |date=March 2009 |pmid=19212636 |doi= |url=}}</ref> | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Typical carcinoid''' | ||
'''Atypical carcinoid''' | '''Atypical carcinoid''' | ||
| | | | ||
* Most common in males | * Most common in males | ||
* Mean age of diagnosis 45 | * Mean age of diagnosis 45 | ||
| | | | ||
* [[Neuroendocrine cells]] of lung | *[[Neuroendocrine cells]] of lung | ||
| | | | ||
* Typical [[Carcinoid|carcinoids]] are throughout the lungs | * Typical [[Carcinoid|carcinoids]] are throughout the lungs | ||
* Atypical carcinoid is more commonly peripheral | * Atypical carcinoid is more commonly peripheral | ||
| | | | ||
* Firm, well demarcated, tan to yellow tumors | * Firm, well demarcated, tan to yellow tumors | ||
| | | | ||
* Uniform polygonal cells | * Uniform polygonal cells | ||
* Nuclear atypia | * Nuclear atypia | ||
* [[Pleomorphism]] | *[[Pleomorphism]] | ||
* The most common patterns are the organoid and trabecular | * The most common patterns are the organoid and trabecular | ||
* Highly vascularized fibrovascular stroma | * Highly vascularized fibrovascular stroma | ||
* Focal [[necrosis]] | * Focal [[necrosis]] | ||
| | | | ||
* [[Cytokeratin]] | *[[Cytokeratin]] | ||
* [[Chromogranin]] | *[[Chromogranin]] | ||
* [[Synaptophysin]] | *[[Synaptophysin]] | ||
* [[CD57]] | *[[CD57]] | ||
* [[CD56]] | *[[CD56]] | ||
* [[S-100 protein]] | *[[S-100 protein]] | ||
| | | | ||
* Well defined [[pulmonary]] nodules | * Well defined [[pulmonary]] nodules | ||
* [[Calcification|Calcifications]] is often seen. | *[[Calcification|Calcifications]] is often seen. | ||
* Intense contrast enhancement | * Intense contrast enhancement | ||
| | | | ||
* [[Liver]] | *[[Liver]] | ||
* [[Bone]] | *[[Bone]] | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref> | | rowspan="3" style="background:#DCDCDC;" align="center" + |'''Salivary gland tumors'''<ref name="pmid23789697">{{cite journal |vauthors=Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM |title=Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome |journal=AJR Am J Roentgenol |volume=201 |issue=1 |pages=W57–63 |date=July 2013 |pmid=23789697 |pmc=3767141 |doi=10.2214/AJR.12.9579 |url=}}</ref> | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''[[Mucoepidermoid carcinoma]]''' | ||
| | | | ||
Line 697: | Line 570: | ||
| | | | ||
* Ranging in size from 0.5-6 cm | * Ranging in size from 0.5-6 cm | ||
* Soft, polypoid, and pink-tan in colour | * Soft, polypoid, and pink-tan in colour | ||
* High-grade lesions are infiltrative | * High-grade lesions are infiltrative | ||
| | | | ||
Line 705: | Line 578: | ||
* Transitional areas to low grade [[mucoepidermoid carcinoma]] | * Transitional areas to low grade [[mucoepidermoid carcinoma]] | ||
| | | | ||
* [[GFAP]] | *[[GFAP]] | ||
| | | | ||
* Well-circumscribed oval or lobulated mass | * Well-circumscribed oval or lobulated mass | ||
* [[Calcification|Calcifications]] | *[[Calcification|Calcifications]] | ||
* Post-obstructive pneumonic infiltrates | * Post-obstructive pneumonic infiltrates | ||
| | | | ||
* Rare | * Rare | ||
* [[Liver]] | *[[Liver]] | ||
* [[Bones]] | *[[Bones]] | ||
* [[Adrenal gland]] | *[[Adrenal gland]] | ||
* [[Brain]] | *[[Brain]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Adenoid cystic carcinoma''' | ||
Line 724: | Line 597: | ||
* Primitive cells of tracheobronchial origin | * Primitive cells of tracheobronchial origin | ||
| | | | ||
* [[Trachea]] | *[[Trachea]] | ||
| | | | ||
* Gray-white or tan polypoid lesions | * Gray-white or tan polypoid lesions | ||
* Size ranges from 1–4 cm | * Size ranges from 1–4 cm | ||
* Infiltrative margins | * Infiltrative margins | ||
Line 734: | Line 607: | ||
* Invades other cell layers | * Invades other cell layers | ||
* Heterogeneous cellularity | * Heterogeneous cellularity | ||
* Cribriform pattern | * Cribriform pattern | ||
* Perineural invasion | * Perineural invasion | ||
| | | | ||
* [[Immunoperoxidase]] | *[[Immunoperoxidase]] | ||
* [[Cytokeratin]] | *[[Cytokeratin]] | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[Actin]] | *[[Actin]] | ||
* [[Calponin]] | *[[Calponin]] | ||
* [[S-100 protein]] | *[[S-100 protein]] | ||
* [[p53]] | *[[p53]] | ||
* [[GFAP]] | *[[GFAP]] | ||
| | | | ||
* Well circumscribed | * Well circumscribed | ||
* Nodule | * Nodule | ||
| | | | ||
* [[Liver]] | *[[Liver]] | ||
* [[Brain]] | *[[Brain]] | ||
* [[Bone]] | *[[Bone]] | ||
* [[Spleen]] | *[[Spleen]] | ||
* [[Kidney]] | *[[Kidney]] | ||
* [[Adrenal glands]] | *[[Adrenal glands]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelial-myoepithelial carcinoma''' | ||
| | | | ||
* Age ranges from 33 to 71 years | * Age ranges from 33 to 71 years | ||
* No association with [[smoking]] | * No association with [[smoking]] | ||
| | | | ||
Line 768: | Line 641: | ||
* White to gray in colour | * White to gray in colour | ||
| | | | ||
* [[Myoepithelial cells]] | *[[Myoepithelial cells]] | ||
* Dual layer of cells lining ducts | * Dual layer of cells lining ducts | ||
* Low mitotic activity | * Low mitotic activity | ||
| | | | ||
* MNF116 | * MNF116 | ||
* EMA | * EMA | ||
* [[SMA]] and [[S-100]] | *[[SMA]] and [[S-100]] | ||
| | | | ||
* Reflects [[airway obstruction]] | * Reflects [[airway obstruction]] | ||
| | | | ||
* [[Breast]] | *[[Breast]] | ||
|- | |- | ||
! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma | ! colspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Variants of lung carcinoma | ||
Line 790: | Line 663: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis | ||
|- | |- | ||
| rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref> | | rowspan="3" style="background:#DCDCDC;" align="center" + |'''Preinvasive lesions'''<ref name="pmid11980589">{{cite journal |vauthors=Greenberg AK, Yee H, Rom WN |title=Preneoplastic lesions of the lung |journal=Respir. Res. |volume=3 |issue= |pages=20 |date=2002 |pmid=11980589 |pmc=107849 |doi= |url=}}</ref> | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Squamous carcinoma in situ''' | ||
| rowspan="3" | | | rowspan="3" | | ||
* Most commonly seen in fifth or sixth decades | * Most commonly seen in fifth or sixth decades | ||
Line 798: | Line 671: | ||
* Basal cells of squamous epithelium | * Basal cells of squamous epithelium | ||
| | | | ||
* [[Bronchi]] | *[[Bronchi]] | ||
| | | | ||
* Focal or multi-focal plaque-like greyish lesions | * Focal or multi-focal plaque-like greyish lesions | ||
* Nonspecific [[erythema]] | * Nonspecific [[erythema]] | ||
* Even nodular or polypoid lesions | * Even nodular or polypoid lesions | ||
| | | | ||
* [[Goblet cell]] [[hyperplasia]] | *[[Goblet cell]] [[hyperplasia]] | ||
* [[Basal cell]] [[hyperplasia]] | *[[Basal cell]] [[hyperplasia]] | ||
* [[Squamous]] [[dysplasia]] | *[[Squamous]] [[dysplasia]] | ||
* [[Angiogenic]] [[squamous]] [[dysplasia]] | *[[Angiogenic]] [[squamous]] [[dysplasia]] | ||
* Micropapillomatosis | * Micropapillomatosis | ||
| | | | ||
* [[EGFR]] | *[[EGFR]] | ||
* [[HER2/neu]] | *[[HER2/neu]] | ||
* [[P53 (protein)|p53]] | *[[P53 (protein)|p53]] | ||
* [[MCM2]] | *[[MCM2]] | ||
* [[Ki-67]] | *[[Ki-67]] | ||
* [[Cytokeratin|Cytokeratin 5/6]] | *[[Cytokeratin|Cytokeratin 5/6]] | ||
* [[Bcl-2]] | *[[Bcl-2]] | ||
* [[VEGF]] | *[[VEGF]] | ||
* Folate binding protein | * Folate binding protein | ||
* [[P16 (gene)|p16]] | *[[P16 (gene)|p16]] | ||
| | | | ||
* Cauliflower like | * Cauliflower like | ||
* Mosaic pattern | * Mosaic pattern | ||
| rowspan="3" | | | rowspan="3" | | ||
* [[Liver]] | *[[Liver]] | ||
* [[Brain]] | *[[Brain]] | ||
* [[Bone]] | *[[Bone]] | ||
* [[Spleen]] | *[[Spleen]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Atypical adenomatous hyperplasia''' | ||
| | | | ||
* Surfactant apoprotein | * Surfactant apoprotein | ||
* [[Clara cell secretory protein|Clara cell specific 10kDd protein]] | *[[Clara cell secretory protein|Clara cell specific 10kDd protein]] | ||
| | | | ||
* [[Pleurae|Pleura]] | *[[Pleurae|Pleura]] | ||
* Upper lobes | * Upper lobes | ||
| | | | ||
* Multiple grey to yellow foci | * Multiple grey to yellow foci | ||
* 1mm to 10mm in size | * 1mm to 10mm in size | ||
| | | | ||
* Intranuclear inclusions | * Intranuclear inclusions | ||
* [[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]] | *[[Clara cell|Clara cells]] and [[Pneumocytes|type II pneumocytes]] | ||
* Thickened alveolar walls | * Thickened alveolar walls | ||
* Discontinuous lining of cells | * Discontinuous lining of cells | ||
* Moderate atypia | * Moderate atypia | ||
* Pseudopapillae | * Pseudopapillae | ||
| | | | ||
* [[CEA]] | *[[CEA]] | ||
* [[MMP|MMPs]] | *[[MMP|MMPs]] | ||
* [[E-cadherin]] | *[[E-cadherin]] | ||
* [[Beta-catenin|ß-catenin]] | *[[Beta-catenin|ß-catenin]] | ||
* [[CD44|CD44v6]] | *[[CD44|CD44v6]] | ||
* [[TTF-1]] | *[[TTF-1]] | ||
* [[TP53]] | *[[TP53]] | ||
| | | | ||
* Typically not visualized on [[Radiography|radiographs]] | * Typically not visualized on [[Radiography|radiographs]] | ||
* Small non-solid nodules | * Small non-solid nodules | ||
* Ground-glass opacity | * Ground-glass opacity | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia''' | ||
| | | | ||
* [[Pulmonary]] [[neuroendocrine cells]] | *[[Pulmonary]] [[neuroendocrine cells]] | ||
| | | | ||
* Endobronchial | * Endobronchial | ||
Line 872: | Line 745: | ||
* Early lesions are: | * Early lesions are: | ||
** Small, gray-white nodules | ** Small, gray-white nodules | ||
** Resembling ‘miliary bodies’ | ** Resembling ‘miliary bodies’ | ||
* Larger [[carcinoid]] tumors are: | * Larger [[carcinoid]] tumors are: | ||
** Firm | ** Firm | ||
** Homogeneous | ** Homogeneous | ||
** Well-defined | ** Well-defined | ||
** Grey or yellow-white masses | ** Grey or yellow-white masses | ||
| | | | ||
* [[Nodular]] aggregates | *[[Nodular]] aggregates | ||
* [[Myelofibrosis|Fibrosis]] due to [[proliferation]] | *[[Myelofibrosis|Fibrosis]] due to [[proliferation]] | ||
* Invade locally | * Invade locally | ||
* [[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’. | *[[Fibrous]] [[stroma]] aggregates to form ‘tumorlets’. | ||
* [[Carcinoid|Carcinoids]] are tumorlets >5cm. | *[[Carcinoid|Carcinoids]] are tumorlets >5cm. | ||
| | | | ||
* [[Keratin]] | *[[Keratin]] | ||
* [[CEA]] | *[[CEA]] | ||
| | | | ||
* Mosaic pattern of air trapping | * Mosaic pattern of air trapping | ||
Line 902: | Line 775: | ||
! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis | ! style="background:#4479BA; color: #FFFFFF;" align="center" + |Metastasis | ||
|- | |- | ||
| rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref> | | rowspan="8" style="background:#DCDCDC;" align="center" + |'''Mesenchymal tumors'''<ref name="pmid24407922">{{cite journal |vauthors=Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP |title=Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms |journal=Insights Imaging |volume=5 |issue=2 |pages=237–44 |date=April 2014 |pmid=24407922 |pmc=3999366 |doi=10.1007/s13244-013-0306-0 |url=}}</ref> | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Epithelioid haemangioendothelioma / Angiosarcoma''' | ||
| | | | ||
Line 910: | Line 783: | ||
* Endothelial cells | * Endothelial cells | ||
| | | | ||
* [[Intravascular]] | *[[Intravascular]] | ||
| | | | ||
* 0.3-2.0 cm circumscribed mass | * 0.3-2.0 cm circumscribed mass | ||
Line 916: | Line 789: | ||
* Yellow flecks | * Yellow flecks | ||
* Central [[Calcification|calcifications]] | * Central [[Calcification|calcifications]] | ||
* Cut surface has a [[cartilaginous]] consistency | * Cut surface has a [[cartilaginous]] consistency | ||
| | | | ||
* Round to oval-shaped [[nodules]] | * Round to oval-shaped [[nodules]] | ||
* Central [[sclerosis]] | * Central [[sclerosis]] | ||
* Hypocellular zone | * Hypocellular zone | ||
* Peripheral cellular zone | * Peripheral cellular zone | ||
* [[Calcification|Calcifications]] | *[[Calcification|Calcifications]] | ||
* Intranuclear [[cytoplasmic]] [[inclusions]] | * Intranuclear [[cytoplasmic]] [[inclusions]] | ||
| | | | ||
* [[CD31]] | *[[CD31]] | ||
* [[CD34]] | *[[CD34]] | ||
* [[Factor VIII]] ([[von Willebrand factor]]) | *[[Factor VIII]] ([[von Willebrand factor]]) | ||
* [[Cytokeratin]] | *[[Cytokeratin]] | ||
| | | | ||
* Multiple | * Multiple | ||
* Bilateral | * Bilateral | ||
* Small nodules | * Small nodules | ||
* 1-2 cm in size | * 1-2 cm in size | ||
* Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]]. | * Can mimic [[Langerhans cell histiocytosis|pulmonary Langerhans’ cell histiocytosis]]. | ||
* [[Calcification|Calcifications]] | *[[Calcification|Calcifications]] | ||
| | | | ||
* [[Liver]] | *[[Liver]] | ||
* [[Bone]] | *[[Bone]] | ||
* [[Soft tissue]] | *[[Soft tissue]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Pleuropulmonary blastoma''' | ||
Line 946: | Line 819: | ||
* Median age of diagnosis is 2 years | * Median age of diagnosis is 2 years | ||
| | | | ||
* [[Thoracic]] splanchnopleural [[mesenchyme]] | *[[Thoracic]] splanchnopleural [[mesenchyme]] | ||
| | | | ||
* [[Pleurae|Pleura]] | *[[Pleurae|Pleura]] | ||
* [[Lung]] | *[[Lung]] | ||
| | | | ||
* Purely cystic | * Purely cystic | ||
* Thin-walled | * Thin-walled | ||
* Rarely solid | * Rarely solid | ||
* Firm to gelatinous | * Firm to gelatinous | ||
Line 966: | Line 839: | ||
** Mixed cells | ** Mixed cells | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[S-100 protein]] | *[[S-100 protein]] | ||
| | | | ||
* Unilateral | * Unilateral | ||
* Localized airfilled cysts | * Localized airfilled cysts | ||
* Septal thickening or an intracystic mass | * Septal thickening or an intracystic mass | ||
| | | | ||
* [[Brain]] | *[[Brain]] | ||
* [[Spinal cord]] | *[[Spinal cord]] | ||
* [[Skeletal system]] | *[[Skeletal system]] | ||
* [[Eye|Eyes]] | *[[Eye|Eyes]] | ||
* [[Pancreas]] | *[[Pancreas]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Chondroma''' | ||
Line 983: | Line 856: | ||
* Young women | * Young women | ||
| | | | ||
* [[Chondrocyte|Chondrocytes]] | *[[Chondrocyte|Chondrocytes]] | ||
* Cartilaginous cells | * Cartilaginous cells | ||
| | | | ||
* Peripheral lesions in [[lung]] | * Peripheral lesions in [[lung]] | ||
* Primary lesion seen in | * Primary lesion seen in | ||
** [[Stomach]] | **[[Stomach]] | ||
** [[Bone]] | **[[Bone]] | ||
** [[Paraganglia]] | **[[Paraganglia]] | ||
| | | | ||
* Peripheral | * Peripheral | ||
* Solid lesions | * Solid lesions | ||
* [[Calcified lesion|Calcified]] | *[[Calcified lesion|Calcified]] | ||
| | | | ||
* Capsulated lobules | * Capsulated lobules | ||
* Hypocellular | * Hypocellular | ||
* Features of [[malignancy]] are absent | * Features of [[malignancy]] are absent | ||
Line 1,006: | Line 879: | ||
* “Pop-corn” calcifications | * “Pop-corn” calcifications | ||
| | | | ||
* [[Benign tumor|Benign]] in nature | *[[Benign tumor|Benign]] in nature | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Congenital peribronchial myofibroblastic tumor''' | ||
Line 1,013: | Line 886: | ||
* Sporadic | * Sporadic | ||
* Complicated by | * Complicated by | ||
** [[Polyhydramnios]] | **[[Polyhydramnios]] | ||
** [[Hydrops fetalis|Non-immune hydrops fetalis]] | **[[Hydrops fetalis|Non-immune hydrops fetalis]] | ||
| | | | ||
* [[Spindle cells]] | *[[Spindle cells]] | ||
| | | | ||
* Along the bronchi | * Along the bronchi | ||
| | | | ||
* 5-10 cm | * 5-10 cm | ||
* Well-circumscribed | * Well-circumscribed | ||
* Non-encapsulated | * Non-encapsulated | ||
* Smooth or multinodular surface | * Smooth or multinodular surface | ||
* The cut surface has a tann-grey to yellow-tan fleshy appearance | * The cut surface has a tann-grey to yellow-tan fleshy appearance | ||
* [[Hemorrhage]] | *[[Hemorrhage]] | ||
* [[Necrosis]] | *[[Necrosis]] | ||
| | | | ||
* [[Fascicles]] of [[spindle cells]] | *[[Fascicles]] of [[spindle cells]] | ||
* [[Bronchial]] invasion | *[[Bronchial]] invasion | ||
* Peribronchial distribution | * Peribronchial distribution | ||
* Cystic foci of [[hemorrhage]] | * Cystic foci of [[hemorrhage]] | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
| | | | ||
* Well circumscribed | * Well circumscribed | ||
* Opaque hemithorax | * Opaque hemithorax | ||
* Heterogeneous mass | * Heterogeneous mass | ||
Line 1,046: | Line 919: | ||
* Young adults of both sexes | * Young adults of both sexes | ||
| | | | ||
* [[Smooth muscle cells]] of [[lymphatic vessels]] | *[[Smooth muscle cells]] of [[lymphatic vessels]] | ||
| | | | ||
* Along the [[Lymphatic drainage|lymphatic distribution]] | * Along the [[Lymphatic drainage|lymphatic distribution]] | ||
| | | | ||
* Prominence of the bronchovascular bundles along | * Prominence of the bronchovascular bundles along | ||
** [[Pleurae|Pleura]] | **[[Pleurae|Pleura]] | ||
** Interlobular pulmonary septa | ** Interlobular pulmonary septa | ||
** [[Mediastinum]] | **[[Mediastinum]] | ||
| | | | ||
* Anastomosing endothelial-lined cells along lymphatic routes | * Anastomosing endothelial-lined cells along lymphatic routes | ||
* [[Spindle cells]] | *[[Spindle cells]] | ||
* Intra alveolar siderophages | * Intra alveolar siderophages | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
| | | | ||
* Increased interstitial markings | * Increased interstitial markings | ||
* Thickening of the: | * Thickening of the: | ||
** Interlobular septa | ** Interlobular septa | ||
** [[Fissure|Fissures]] | **[[Fissure|Fissures]] | ||
** Central airways | ** Central airways | ||
** [[Pleura]] | **[[Pleura]] | ||
| | | | ||
* Skin | * Skin | ||
Line 1,076: | Line 949: | ||
| | | | ||
* Previous [[viral infections]] | * Previous [[viral infections]] | ||
* [[HHV-8|HHV8]] | *[[HHV-8|HHV8]] | ||
* Children | * Children | ||
| | | | ||
* [[Myofibroblasts|Myofibroblastic cells]] | *[[Myofibroblasts|Myofibroblastic cells]] | ||
| | | | ||
* Localized to bronchi | * Localized to bronchi | ||
Line 1,089: | Line 962: | ||
* Yellowish-gray discoloration | * Yellowish-gray discoloration | ||
* Average size of 3.0 cm | * Average size of 3.0 cm | ||
* Non-encapculated | * Non-encapculated | ||
* [[Calcification|Calcifications]] | *[[Calcification|Calcifications]] | ||
* No local invasion | * No local invasion | ||
| | | | ||
* Mixture of [[spindle cells]] | * Mixture of [[spindle cells]] | ||
** [[Fibroblastic]] | **[[Fibroblastic]] | ||
** [[Myofibroblasts|Myofibroblastic]] | **[[Myofibroblasts|Myofibroblastic]] | ||
* Arranged in [[fascicles]] | * Arranged in [[fascicles]] | ||
* Cytologic atypia | * Cytologic atypia | ||
* Touton type [[giant cells]] | * Touton type [[giant cells]] | ||
* [[Plasma cells]] | *[[Plasma cells]] | ||
* [[Lymphoid follicles]] | *[[Lymphoid follicles]] | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[Actin]] | *[[Actin]] | ||
* p80 | * p80 | ||
| | | | ||
* Solitary mass | * Solitary mass | ||
* Regular borders | * Regular borders | ||
* Spiculated appearance | * Spiculated appearance | ||
* Accompanied by | * Accompanied by | ||
** Post-obstructive [[pneumonia]] | ** Post-obstructive [[pneumonia]] | ||
** [[Atelectasis]] | **[[Atelectasis]] | ||
| | | | ||
* Rare | * Rare | ||
Line 1,120: | Line 993: | ||
* Commonly misdiagnosed as [[pulmonary embolism]] | * Commonly misdiagnosed as [[pulmonary embolism]] | ||
| | | | ||
* [[Mesenchymal cell|Mesenchymal cells]] of the [[intima]] | *[[Mesenchymal cell|Mesenchymal cells]] of the [[intima]] | ||
* Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]] | * Primitive cells of the bulbus cordi in the trunk of [[pulmonary artery]] | ||
| | | | ||
* [[Pulmonary trunk]] most commonly involving: | *[[Pulmonary trunk]] most commonly involving: | ||
** [[Right pulmonary artery]] | **[[Right pulmonary artery]] | ||
** [[Left pulmonary artery]] | **[[Left pulmonary artery]] | ||
** [[Pulmonary valve]] | **[[Pulmonary valve]] | ||
** [[Ventricular outflow tract|Right ventricular outflow tract]] | **[[Ventricular outflow tract|Right ventricular outflow tract]] | ||
| | | | ||
* Mucoid or gelatinous clots filling vascular lumens | * Mucoid or gelatinous clots filling vascular lumens | ||
Line 1,133: | Line 1,006: | ||
** Firm fibrotic areas | ** Firm fibrotic areas | ||
** Bony/gritty or chondromyxoid foci | ** Bony/gritty or chondromyxoid foci | ||
** [[Hemorrhage]] and [[necrosis]] are common in high-grade tumors | **[[Hemorrhage]] and [[necrosis]] are common in high-grade tumors | ||
| | | | ||
* Spindle cells in | * Spindle cells in | ||
** A myxoid background | ** A myxoid background | ||
** Collagenized stroma | ** Collagenized stroma | ||
** Recanalized thrombi | ** Recanalized thrombi | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[Osteopontin]] | *[[Osteopontin]] | ||
* [[Factor VIII]] | *[[Factor VIII]] | ||
* [[CD31]] | *[[CD31]] | ||
* [[CD34]] | *[[CD34]] | ||
| rowspan="2" | | | rowspan="2" | | ||
* Findings overlap with those of chronic [[thromboembolic disease]] | * Findings overlap with those of chronic [[thromboembolic disease]] | ||
* Decreased [[vascularity]] | * Decreased [[vascularity]] | ||
* Heterogeneous [[soft tissue]] density | * Heterogeneous [[soft tissue]] density | ||
* Smooth [[vascular]] tapering | * Smooth [[vascular]] tapering | ||
| | | | ||
* [[Lung]] parenchyma | *[[Lung]] parenchyma | ||
* [[Mediastinum]] | *[[Mediastinum]] | ||
|- | |- | ||
| colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma''' | | colspan="2" style="background:#DCDCDC;" align="center" + |'''Pulmonary vein sarcoma''' | ||
Line 1,159: | Line 1,032: | ||
* Mean age of diagnosis is 49 | * Mean age of diagnosis is 49 | ||
| | | | ||
* [[Smooth muscle]] | *[[Smooth muscle]] | ||
| | | | ||
* [[Pulmonary veins|Pulmonary vein]] | *[[Pulmonary veins|Pulmonary vein]] | ||
| | | | ||
* Fleshy-tan tumor | * Fleshy-tan tumor | ||
Line 1,168: | Line 1,041: | ||
* Invasion of wall of the [[vein]] | * Invasion of wall of the [[vein]] | ||
| | | | ||
* [[Smooth muscle]] differentiation | *[[Smooth muscle]] differentiation | ||
* Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]] | * Moderate to highly cellular [[Spindle cells|spindle cell]] [[neoplasms]] | ||
* [[Epithelioid]] morphology | *[[Epithelioid]] morphology | ||
| | | | ||
* [[Vimentin]] | *[[Vimentin]] | ||
* [[Desmin]] | *[[Desmin]] | ||
* [[Actin]] | *[[Actin]] | ||
* [[Keratin]] | *[[Keratin]] | ||
| | | | ||
* N/A | * N/A | ||
|} | |} | ||
=== '''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.'''<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref> === | ==='''The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.'''<ref name="pmid4353362">{{cite journal |vauthors=Chaudhuri MR |title=Primary pulmonary cavitating carcinomas |journal=Thorax |volume=28 |issue=3 |pages=354–66 |year=1973 |pmid=4353362 |pmc=470041 |doi= |url=}}</ref><ref name="pmid8572761">{{cite journal |vauthors=Mouroux J, Padovani B, Elkaïm D, Richelme H |title=Should cavitated bronchopulmonary cancers be considered a separate entity? |journal=Ann. Thorac. Surg. |volume=61 |issue=2 |pages=530–2 |year=1996 |pmid=8572761 |doi=10.1016/0003-4975(95)00973-6 |url=}}</ref><ref name="pmid10377211">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid103772112">{{cite journal |vauthors=Langford CA, Hoffman GS |title=Rare diseases.3: Wegener's granulomatosis |journal=Thorax |volume=54 |issue=7 |pages=629–37 |year=1999 |pmid=10377211 |pmc=1745525 |doi= |url=}}</ref><ref name="pmid22429393">{{cite journal |vauthors=Suri HS, Yi ES, Nowakowski GS, Vassallo R |title=Pulmonary langerhans cell histiocytosis |journal=Orphanet J Rare Dis |volume=7 |issue= |pages=16 |year=2012 |pmid=22429393 |pmc=3342091 |doi=10.1186/1750-1172-7-16 |url=}}</ref>=== | ||
{| class="wikitable" | {| class="wikitable" | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" + |Disease | ||
Line 1,202: | Line 1,075: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Acute Lung abscess | | style="background:#DCDCDC;" align="center" + |Acute Lung abscess | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|'''-''' | |'''-''' | ||
Line 1,221: | Line 1,094: | ||
([[Lung cancer|primary lung cancer]]) | ([[Lung cancer|primary lung cancer]]) | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
| | | | ||
*Coin-shaped lesion | *Coin-shaped lesion | ||
*Thick wall(>15mm) | *Thick wall(>15mm) | ||
*Ground glass opacities | *Ground glass opacities | ||
Line 1,240: | Line 1,113: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]] | | style="background:#DCDCDC;" align="center" + |[[Tuberculosis, pulmonary|Pulmonary Tuberculosis]] | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| | | | ||
*[[Cavitation|Cavitations]] in the upper lobe of the [[lung]] | *[[Cavitation|Cavitations]] in the upper lobe of the [[lung]] | ||
Line 1,257: | Line 1,130: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |[[Pneumonia|Necrotizing Pneumonia]] | | style="background:#DCDCDC;" align="center" + |[[Pneumonia|Necrotizing Pneumonia]] | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| | | | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 1,276: | Line 1,149: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |Empyema | | style="background:#DCDCDC;" align="center" + |Empyema | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 1,293: | Line 1,166: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 1,307: | Line 1,180: | ||
*Increased [[pulmonary]] markings | *Increased [[pulmonary]] markings | ||
*Honeycombing | *Honeycombing | ||
*[[Atelectasis]] | *[[Atelectasis]] | ||
| | | | ||
* CT confirms the diagnosis | * CT confirms the diagnosis | ||
Line 1,314: | Line 1,187: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| | | | ||
| + | | + | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
*[[Pulmonary]] [[nodules]] | *[[Pulmonary]] [[nodules]] | ||
*[[Cavities]] | *[[Cavities]] | ||
*Infiltrates | *Infiltrates | ||
Line 1,331: | Line 1,204: | ||
|- | |- | ||
| style="background:#DCDCDC;" align="center" + |[[Sarcoidosis]] | | style="background:#DCDCDC;" align="center" + |[[Sarcoidosis]] | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
| | | | ||
*[[Bilateral]] [[Lymphadenopathy|adenopathy]] | *[[Bilateral]] [[Lymphadenopathy|adenopathy]] | ||
*Coarse reticular opacities | *Coarse reticular opacities | ||
| | | | ||
*More common in African-american females | *More common in African-american females | ||
Line 1,354: | Line 1,227: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 1,371: | Line 1,244: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| | | | ||
Line 1,385: | Line 1,258: | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
| + | | + | ||
| + | | + | ||
| + | | + | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
|<nowiki>-</nowiki> | |<nowiki>-</nowiki> | ||
Line 1,395: | Line 1,268: | ||
* Patchy [[Consolidation (medicine)|consolidation,]] | * Patchy [[Consolidation (medicine)|consolidation,]] | ||
* Ground-glass opacities | * Ground-glass opacities | ||
* [[Nodules]] | *[[Nodules]] | ||
| | | | ||
* Biopsy | * Biopsy |
Latest revision as of 05:40, 17 February 2021
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2] , Eiman Ghaffarpasand, M.D. [3],
Overview
Lung cancer must be differentiated from other conditions that cause hemoptysis, cough, dyspnea, wheezing, chest pain, dysphonia, dysphagia, unexplained weight loss, unexplained loss of appetite, and fatigue. These conditions include pneumonia, bronchitis, metastatic cancer from a non-thoracic primary site, infectious granuloma, pulmonary tuberculosis, tracheal tumors, and a thyroid mass.
Differentiating Lung Cancer from Other Diseases
The following table summarizes the differentiation of various lung tumors based on histological and topographical features:[1]
Abrevations:
HPV: human papillomavirus; CEA: Carcino embryogenic antigen; TTF1: Thyroid transcription factor-1; EMA: Epithelial membrane antigen; CK: Cyto keratin; CD: Cluster differentiation; NCAM: Neural Cell Differentiation Molecule; MMP's: Mettaloprotineases matrix ; GFAP: Glial fibrocilliary acid protein | ||||||||||
---|---|---|---|---|---|---|---|---|---|---|
Benign Lung Tumors[2] | ||||||||||
Benign lung tumor | Risk/Epidemiology | Pleuripotent cells | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Papilloma[3] | Squamous cell papilloma |
|
|
|
|
|
| |||
Glandular papilloma |
|
|
|
|
|
|
| |||
Adenoma[4] | Alveolar adenoma |
|
|
|
|
|
|
| ||
Papillary adenoma[5] |
|
|
|
|
|
|
|
| ||
Mucinous cystadenoma |
|
|
|
|
|
|
|
| ||
Malignant Lung Tumors[6] | ||||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Squamous cell carcinoma (SCC)[7] | Papillary |
|
|
|
|
|
|
|||
Clear cell |
| |||||||||
Basaloid |
| |||||||||
Small cell carcinoma[8] |
|
|
|
|
|
| ||||
Adenocarcinoma[9][10][11] | Acinar adenocarcinoma |
|
|
|
|
|
Aerogenous spread is characteristic
| |||
Papillary adenocarcinoma |
| |||||||||
Bronchio-alveolar carcinoma | Non-mucinous | |||||||||
Mucinous |
| |||||||||
Mixed non-mucinous and mucinous or indeterminate |
| |||||||||
Solid adenocarcinoma with mucin production | Fetal adenocarcinoma |
| ||||||||
Mucinous (“colloid”) carcinoma |
| |||||||||
Mucinous cystadenocarcinoma |
| |||||||||
Signet ring adenocarcinoma |
| |||||||||
Clear cell adenocarcinoma |
| |||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Large cell carcinoma[12] | Basaloid large cell carcinoma of the lung |
|
|
|
|
|
|
| ||
Clear cell carcinoma of the lung | ||||||||||
Lymphoepithelioma-like carcinoma of the lung |
| |||||||||
Large-cell lung carcinoma with rhabdoid phenotype |
| |||||||||
Mixed type |
| |||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Sarcomatoid carcinoma[13] | Carcinosarcoma |
|
|
|
|
|
|
|||
Spindle cell carcinoma |
|
|||||||||
Giant cell carcinoma |
| |||||||||
Pleomorphic carcinoma |
| |||||||||
Pulmonary blastoma |
|
| ||||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Carcinoid tumor[14] | Typical carcinoid
Atypical carcinoid |
|
|
|
|
|
|
|||
Salivary gland tumors[15] | Mucoepidermoid carcinoma |
|
|
|
|
|
|
| ||
Adenoid cystic carcinoma |
|
|
|
|
|
|||||
Epithelial-myoepithelial carcinoma |
|
|
|
|
|
|||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Preinvasive lesions[16] | Squamous carcinoma in situ |
|
|
|
|
|
||||
Atypical adenomatous hyperplasia |
|
|
|
|
| |||||
Diffuse idiopathic pulmonary neuroendocrine cell hyperplasia |
|
|
|
| ||||||
Variants of lung carcinoma | Risk Factors/Epidemiology | Pleuripotent cell | Topography | Gross | Histology | Immunohistochemistry | Imaging | Metastasis | ||
Mesenchymal tumors[17] | Epithelioid haemangioendothelioma / Angiosarcoma |
|
|
|
|
|
||||
Pleuropulmonary blastoma |
|
|
|
|
|
|||||
Chondroma |
|
|
|
|
|
|
|
| ||
Congenital peribronchial myofibroblastic tumor |
|
|
|
|
|
| ||||
Diffuse pulmonary lymphangiomatosis |
|
|
|
|
|
| ||||
Inflammatory myofibroblastic tumor |
|
|
|
|
|
| ||||
Pulmonary artery sarcoma |
|
|
|
|
|
|
| |||
Pulmonary vein sarcoma |
|
|
|
|
The following table summarizes the differentiation of lung cancer from other disease entities with similar presentation.[18][19][20][21][22]
Disease | Clinical features
Signs & symptoms |
Radiological Findings | Characterstic feature | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Fever | Cough | Hemoptysis | Dyspnea | Chest pain | Weight loss | Night sweats | |||||
High-grade | Low grade | Productive | Dry | ||||||||
Acute Lung abscess | + | - | + | - | - | - | + | - | - |
|
|
Malignancy | - | + | - | + | + | - | - | + | + |
|
|
Pulmonary Tuberculosis | + | - | + | - | + | - | - | - | + |
|
|
Necrotizing Pneumonia | + | - | + | + | - | + | - | - |
|
| |
Empyema | + | - | + | - | + | + | + | - | - |
|
|
Bronchiectasis | - | - | + | - | + | - | - | - | - |
|
|
Wegners granulomatosis | - | - | + | + | + | - | - | - |
| ||
Sarcoidosis | + | - | + | - | + | - | - | + | + |
|
|
Rheumatoid nodule | - | - | - | - | - | + | - | + | - |
|
|
Langerhans cell Histiocytosis | - | - | - | - | - | + | + | + | - |
|
|
Bronchiolitis obliterans | - | - | + | - | + | + | + | - | - |
|
|
References
- ↑ Erasmus JJ, Connolly JE, McAdams HP, Roggli VL (2000). "Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions". Radiographics. 20 (1): 43–58. doi:10.1148/radiographics.20.1.g00ja0343. PMID 10682770.
- ↑ Gümüştaş S, Inan N, Akansel G, Ciftçi E, Demirci A, Ozkara SK (June 2012). "Differentiation of malignant and benign lung lesions with diffusion-weighted MR imaging". Radiol Oncol. 46 (2): 106–13. doi:10.2478/v10019-012-0021-3. PMC 3472932. PMID 23077446.
- ↑ Maxwell RJ, Gibbons JR, O'Hara MD (January 1985). "Solitary squamous papilloma of the bronchus". Thorax. 40 (1): 68–71. PMC 459982. PMID 3969658.
- ↑ Shiota Y, Matsumoto H, Sasaki N, Taniyama K, Hashimoto S, Sueishi K (1998). "Solitary bronchioloalveolar adenoma of the lung". Respiration. 65 (6): 483–5. doi:10.1159/000029319. PMID 9817965.
- ↑ Kanchustambham V, Saladi S, Patolia S, Mahmoud Assaf S, Stoeckel D (March 2017). "A Rare Case of a Benign Primary Pleomorphic Adenoma of the Lung". Cureus. 9 (3): e1069. doi:10.7759/cureus.1069. PMC 5375953. PMID 28409070.
- ↑ Kelley LC, Puette M, Langheinrich KA, King B (November 1994). "Bovine pulmonary blastomas: histomorphologic description and immunohistochemistry". Vet. Pathol. 31 (6): 658–62. doi:10.1177/030098589403100605. PMID 7863581.
- ↑ Roth E, Smidt D (January 1970). "[Studies on early ejaculate collection using electroejaculation in German improved land-swines and Goettinger miniature pigs]". Berl. Munch. Tierarztl. Wochenschr. (in German). 83 (1): 7–11. PMID 5528918.
- ↑ Jackman DM, Johnson BE (2005). "Small-cell lung cancer". Lancet. 366 (9494): 1385–96. doi:10.1016/S0140-6736(05)67569-1. PMID 16226617.
- ↑ Mitchell, Richard Sheppard; Kumar, Vinay; Abbas, Abul K.; Fausto, Nelson. "Chapter 13, box on morphology of adenocarcinoma". Robbins Basic Pathology (8th ed.). Philadelphia: Saunders. ISBN 1-4160-2973-7.
- ↑ Soda M, Choi YL, Enomoto M, Takada S, Yamashita Y, Ishikawa S; et al. (2007). "Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer". Nature. 448 (7153): 561–6. doi:10.1038/nature05945. PMID 17625570.
- ↑ Adenocarcinoma of the lung. Librepathology 2015. http://librepathology.org/wiki/index.php/File:Adenocarcinoma_%283950819000%29.jpg
- ↑ Rossi G, Mengoli MC, Cavazza A, Nicoli D, Barbareschi M, Cantaloni C, Papotti M, Tironi A, Graziano P, Paci M, Stefani A, Migaldi M, Sartori G, Pelosi G (January 2014). "Large cell carcinoma of the lung: clinically oriented classification integrating immunohistochemistry and molecular biology". Virchows Arch. 464 (1): 61–8. doi:10.1007/s00428-013-1501-6. PMID 24221342.
- ↑ Huang SY, Shen SJ, Li XY (October 2013). "Pulmonary sarcomatoid carcinoma: a clinicopathologic study and prognostic analysis of 51 cases". World J Surg Oncol. 11: 252. doi:10.1186/1477-7819-11-252. PMC 3850921. PMID 24088577.
- ↑ Dahabreh J, Stathopoulos GP, Koutantos J, Rigatos S (March 2009). "Lung carcinoid tumor biology: treatment and survival". Oncol. Rep. 21 (3): 757–60. PMID 19212636.
- ↑ Elnayal A, Moran CA, Fox PS, Mawlawi O, Swisher SG, Marom EM (July 2013). "Primary salivary gland-type lung cancer: imaging and clinical predictors of outcome". AJR Am J Roentgenol. 201 (1): W57–63. doi:10.2214/AJR.12.9579. PMC 3767141. PMID 23789697.
- ↑ Greenberg AK, Yee H, Rom WN (2002). "Preneoplastic lesions of the lung". Respir. Res. 3: 20. PMC 107849. PMID 11980589.
- ↑ Koenigkam-Santos M, Sommer G, Puderbach M, Safi S, Schnabel PA, Kauczor HU, Heussel CP (April 2014). "Primary intrathoracic malignant mesenchymal tumours: computed tomography features of a rare group of chest neoplasms". Insights Imaging. 5 (2): 237–44. doi:10.1007/s13244-013-0306-0. PMC 3999366. PMID 24407922.
- ↑ Chaudhuri MR (1973). "Primary pulmonary cavitating carcinomas". Thorax. 28 (3): 354–66. PMC 470041. PMID 4353362.
- ↑ Mouroux J, Padovani B, Elkaïm D, Richelme H (1996). "Should cavitated bronchopulmonary cancers be considered a separate entity?". Ann. Thorac. Surg. 61 (2): 530–2. doi:10.1016/0003-4975(95)00973-6. PMID 8572761.
- ↑ Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Langford CA, Hoffman GS (1999). "Rare diseases.3: Wegener's granulomatosis". Thorax. 54 (7): 629–37. PMC 1745525. PMID 10377211.
- ↑ Suri HS, Yi ES, Nowakowski GS, Vassallo R (2012). "Pulmonary langerhans cell histiocytosis". Orphanet J Rare Dis. 7: 16. doi:10.1186/1750-1172-7-16. PMC 3342091. PMID 22429393.